Stay ConnectedThe Kidney Commute podcast seeks to enhance the work of the interprofessional kidney care team by providing connection through education and CE credits for eligible listeners, while the Pitstop sub-series is a non-accredited exploration of what drives innovation in the nephrology field.
Two opportunities to learn, one opportunity to earn.
Copyright: © Copyright 2021 All rights reserved.
Palliative care, or treatment focused on symptom management and quality of life, is an important and often overlooked aspect of care for people with kidney disease. Similarly, conservative treatment of advanced kidney disease, or medical management without dialysis or transplantation, is not well understood by patients and care providers alike. In this episode of the Kidney Commute, our interprofessional team discusses these two important aspects of kidney disease care.
This episode offers CME/CE credit to eligible listeners. If you'd like to claim credit, please go to kidney.org/podcast-CE to register for this episode and complete requirements.
Cancer is the leading cause of death in the world, associated with high morbidity and mortality. This episode discusses how kidneys are affected by cancer and its treatment. Panelists discuss diagnosing and managing complex kidney problems, such as acute kidney injury associated with cancer and novel oncological therapies, as well as summarize drug dosing in patients with cancer. Thanks for joining us on this ride of the Kidney Commute.
This episode offers CME/CE credit to eligible listeners. If you'd like to claim credit, please go to kidney.org/podcast-CE to register for this episode and complete requirements.
2025 will bring BIG changes to the dialysis world. As of Jan 01, oral phosphorus binders will be part of the dialysis payment bundle, out-of-pocket costs for prescription medications are changing in amounts and payment models, and coverage for certain dental services is expanding, to name a few. In this episode we will explore how these changes will likely impact patients, nephrologists, and dialysis units. Thanks for joining us on this ride of the Kidney Commute!
This episode offers CME/CE credit to eligible listeners. If you'd like to claim credit, please go to kidney.org/podcast-CE to register for this episode and complete requirements.
Patients and care team members often encounter challenges faced by individuals from different cultural backgrounds regarding access to kidney transplantation. This episode explores the impact of a culturally sensitive approach to living donation. Panelists will discuss resources to assist with approaching these conversations effectively while taking into consideration patient-specific factors such as culture, ethnicity, language and religious beliefs. Thanks for joining us on this ride of the Kidney Commute.
This episode offers CME/CE credit to eligible listeners. If you'd like to claim credit, please go to kidney.org/podcast-CE to register for this episode and complete requirements.
Do all patients with chronic kidney disease (CKD) need potassium restriction? In this episode we will explore the current guidelines of potassium intake in different CKD populations. Apart from the guidelines, we will explore the potassium concentration in foods and some tips and tricks for counseling patients. After listening to this episode, you will be in a better position to talk to patients about their potassium needs. Thanks for joining us on this ride of the Kidney Commute.
This episode offers CME/CE credit to eligible listeners. If you'd like to claim credit, go to kidney.org/podcast-CE to register for this episode and complete requirements.
People with kidney disease are at an increased risk for atherosclerotic cardiovascular disease, or ASCVD, and cardiovascular disease is the leading cause of death in people with kidney disease. In this episode of the Kidney Commute our interprofessional panel of experts discusses what ASCVD is, how patients can be evaluated for their ASCVD risk, and strategies for managing and reducing this risk. We cover risk calculators, pharmaceutical options, communication strategies, and areas where we can all work together to educate patients about risk. Thank you for joining us on this ride of The Kidney Commute!
Click here to claim CE Credit.
In this episode of the Kidney Commute podcast, panelists delve into the role of glucagon-like peptide-1 (GLP-1) receptor agonists in chronic kidney disease. The discussion explores the mechanisms of GLP-1 receptor agonists, their benefits in managing both kidney disease and related comorbidities like diabetes and cardiovascular disease, and the latest evidence supporting their use. Panelists also address practical challenges faced by both patients and providers. Click here to claim CE Credit.
Home hemodialysis (HHD) is hemodialysis that is performed at home entirely by a patient or with assistance from a care partner. Solo HHD is when a person performs their own hemodialysis at home without a care partner present. Solo HHD can be challenging for patients and requires the whole care team coming together with the patient to develop an individualized approach for each patient in order to increase their likelihood of success. This episode will discuss common safety concerns and other barriers to solo HHD encountered by patients and offer some potential strategies for overcoming these.
Click here to claim CE credit.
Join our team in a discussion about diagnosis and treatment of glomerulonephritis, a common cause of kidney failure. We explore new treatment options and ways to engage patients in conversations about these options. Additionally, we unpack how to diagnose and monitor glomerulonephritis. This discussion also includes challenges faced both by patients and providers with regard to glomerulonephritis, especially for women of child-bearing age.
Click here to claim CE credits.
The management of patients living with kidney disease is evolving as the complexity of patient care evolves. Join us as we discuss the team of clinicians who are involved in the care of patients with kidney disease, including nephrologists and advanced practice providers (APPs) - advanced practice registered nurses (APRNs) and physician assistants (PAs). This episode will review the roles of each provider type and what each brings to the team as well as the patients. It will also highlight the strengths of team-based care as well as what patients and their families can expect from an APP during clinic visits, hospitalizations, transplant workups, and on dialysis units.
Click here to claim CE credits.
Our TOPPODCAST Picks 
